Annovis Bio, Inc. — Director's Dealing 2023

Nov 22, 2023

SEC Form 4/A — Form 4/A

Issuer: Annovis Bio, Inc. (ANVS)
CIK: 0001477845
Period of Report: 2023-11-20

Reporting Person: McCarthy Reid (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-20	Common Stock	J	0	—	Acquired	7305	Direct

Footnotes

F1: This amendment is being filed solely to reverse the previously reported purchase on the original form 4 filed on November 21, 2023 (the "Original Form 4"). Such purchase was rescinded by the registrant and the reporting person on November 22, 2023.